ClinicalTrials.Veeva

Menu

The Utility of Osteopathic Manipulative Medicine in Weaning Patients from the Ventilator Pilot Trial

O

Oklahoma State University Center for Health Sciences

Status

Not yet enrolling

Conditions

Respiratory Failure
Osteopathy in Diseases Classified Elsewhere

Treatments

Procedure: Osteopathic Manipulative Treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT06891248
2024193

Details and patient eligibility

About

The objectives of this research are to determine the treatment effect size of OMM to wean patients off of the ventilator, determine the number of patients needed for a larger study (power), determine the willingness of patients/POAs to be recruited, identify the correct dosing of OMM and whether there are concerns for the safety of treatment, and determine whether the hypothesis is feasible for a larger study. The primary outcome measure is the duration of time until a subject is weaned off of mechanical ventilation using Osteopathic Manipulative Medicine (OMM). The secondary outcome measures (see the next section for further explanation) are to determine if OMM affects changes in morbidity and mortality, such as VBG/ABG, NIF, RSBI, P 0.1, FiO2, PEEP, mental status, hemodynamic stability (blood pressure), spontaneous TV, reintubation after extubation, and death.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Acute respiratory failure (hypoxic, hypercapnic, or neuromuscular)
  2. Not making satisfactory progress with weaning after being on the ventilator for more than 48 hours
  3. Clinical stability for pressure support trial with ventilator to monitor ventilation progression
  4. Pulmonology must be following the patient for standardized ventilator management approach and interventions as needed
  5. Medical power of attorney (POA) or legally authorized representative (LAR) who is able to consent subject for trial enrollment and treatment
  6. Patients who were not referred to the OMM service

Exclusion criteria

  1. Age less than 18 years old or more than 85 years old
  2. BMI>60
  3. Moderate/severe neurological disease with expectation of non-progression off the ventilator or poor quality of life predicted (including end-stage dementia with the expectation of non-progression off ventilator, multiple sclerosis, ALS, anoxic brain injury, etc)
  4. Status epilepticus or EEG result pending
  5. Post-arrest hypothermia protocol
  6. Acute stroke
  7. Acute rib fractures preventing the implementation of the treatment protocol
  8. Acute spinal injury preventing the implementation of the treatment protocol
  9. Recent head injury requiring close clinical monitoring
  10. Ejection Fraction less than 15%
  11. Pleural effusion requiring procedural intervention or inhibiting ventilator progress
  12. Pericardial effusion or tamponade requiring procedural intervention or inhibiting ventilator progress
  13. ACLS/cardiac arrest within the past 72 hours
  14. Confirmed opioid overdose with positive urine drug screen and response to naloxone
  15. Patients who were referred to the OMM service

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

20 participants in 2 patient groups

Control
No Intervention group
Description:
Subjects in these arms only receive conventional care
Osteopathic Manipulative Treatment
Experimental group
Description:
The standard OMM treatment arm includes a 10-minute treatment time for 5 body regions with up to 3 providers working on the patient simultaneously. The OMM attending physician will be physically present and supervising the treatment, and may be participating in the treatment. The 5 body regions include Head, Neck, Thoracic, Ribs, and Abdominal/Diaphragm. The standard technique for the OMM arm includes OA decompression, screening and treating any cervical dysfunction, thoracic inlet myofascial release, rib raising, thoracic paraspinal inhibition, and abdominal diaphragm myofascial release. There is an opportunity for an additional 5 minutes of treatment time and additional regions if the lead physician determines it is appropriate based on clinical judgment. The additional 4 regions include Upper Extremity, Lower Extremity, Lumbar, Pelvis, and Sacrum.
Treatment:
Procedure: Osteopathic Manipulative Treatment

Trial contacts and locations

0

Loading...

Central trial contact

Cameron Henderson, DO; Leslie Ching, DO

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems